Omalizumab



Indications and Reactions:

Role Indications Reactions
Primary
Asthma 33.0%
Drug Use For Unknown Indication 29.9%
Product Used For Unknown Indication 23.5%
Hypersensitivity 4.7%
Pregnancy 1.6%
Gastrooesophageal Reflux Disease 1.3%
Hypertension 0.9%
Headache 0.6%
Pain 0.6%
Inflammation 0.6%
Depression 0.5%
Anxiety 0.4%
Back Pain 0.4%
Nausea 0.4%
Incision Site Pain 0.3%
Dyspepsia 0.3%
Insomnia 0.3%
Streptococcal Infection 0.2%
Sinusitis 0.2%
Neonatal Respiratory Distress Syndrome 0.2%
Asthma 19.9%
Death 10.1%
Wheezing 9.4%
Anaphylactic Reaction 9.2%
Pneumonia 5.6%
Drug Exposure During Pregnancy 5.0%
Maternal Exposure During Pregnancy 4.6%
Hypersensitivity 4.2%
Respiratory Distress 3.9%
Nasopharyngitis 3.2%
Sinusitis 3.1%
Status Asthmaticus 2.8%
Dyspnoea 2.7%
Rash 2.7%
Maternal Exposure Timing Unspecified 2.6%
Migraine 2.6%
Urticaria 2.4%
Weight Increased 2.2%
Vomiting 1.9%
Bronchitis 1.8%
Secondary
Product Used For Unknown Indication 34.1%
Asthma 33.4%
Drug Use For Unknown Indication 12.0%
Hypersensitivity 6.1%
Headache 1.9%
Pregnancy 1.8%
Nausea 1.2%
Pain 1.1%
Depression 1.0%
Dyspepsia 1.0%
Migraine 0.9%
Procedural Pain 0.9%
Hypertension 0.8%
Gastrooesophageal Reflux Disease 0.7%
Type 2 Diabetes Mellitus 0.7%
Anxiety 0.6%
Diabetic Neuropathy 0.5%
Infertility 0.4%
Rosacea 0.4%
Constipation 0.4%
Asthma 14.4%
Maternal Exposure During Pregnancy 9.1%
Wheezing 7.8%
Throat Irritation 6.4%
Abortion Spontaneous 5.5%
White Blood Cell Count Increased 5.3%
Nasopharyngitis 5.2%
Weight Increased 5.2%
Spirometry 4.1%
Weight Decreased 3.8%
Nausea 3.6%
Pneumonia 3.6%
Type 2 Diabetes Mellitus 3.6%
Influenza 3.4%
Visual Impairment 3.4%
Malaise 3.3%
Pharyngitis 3.1%
Vaginal Haemorrhage 3.1%
Vomiting 3.1%
Exposure During Pregnancy 3.0%
Concomitant
Asthma 41.5%
Product Used For Unknown Indication 16.1%
Bronchopulmonary Aspergillosis Allergic 10.2%
Hypertension 5.9%
Back Pain 3.4%
Diabetes Mellitus 3.4%
Pulmonary Embolism 2.5%
Arthritis 1.7%
Cataplexy 1.7%
Chronic Obstructive Pulmonary Disease 1.7%
Drug Use For Unknown Indication 1.7%
Gastrooesophageal Reflux Disease 1.7%
Hypersensitivity 1.7%
Swelling 1.7%
Angina Pectoris 0.8%
Cardiac Disorder 0.8%
Convulsion 0.8%
Crohn's Disease 0.8%
Insomnia 0.8%
Osteoarthritis 0.8%
Angioedema 7.7%
Hypoventilation 7.7%
Intra-abdominal Haematoma 7.7%
Rhinitis 7.7%
Vomiting 7.7%
Wheezing 7.7%
Asthenia 3.8%
Condition Aggravated 3.8%
Convulsion 3.8%
Drug Dependence 3.8%
Epidural Lipomatosis 3.8%
Mental Status Changes 3.8%
Obstructive Airways Disorder 3.8%
Pneumonia 3.8%
Poor Quality Sleep 3.8%
Pulmonary Function Test Abnormal 3.8%
Restlessness 3.8%
Spinal Cord Compression 3.8%
Therapeutic Response Decreased 3.8%
Thrombocytopenia 3.8%